This inventor holds 1 USPTO granted patent. Top assignee: Vyzkumny Ustav Pro Farmacii a Biochemii. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Zdenek Hlinak: Innovator in Neuroprotective Treatments
Introduction
Zdenek Hlinak is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of neuroprotection, particularly in the treatment of central nervous system disorders. His innovative approach has the potential to improve the lives of many individuals suffering from such conditions.
Latest Patents
Hlinak holds a patent for a neuroprotective composition aimed at preventing or treating central nervous system disorders. The patent describes a method for treating conditions that arise from head injuries or brain ischemia. The method involves administering an effective amount of cyclo-(L-alanyl-1-amino-1-cyclopentane carbonyl) to a mammalian organism in need of treatment. This administration can be performed either orally or parenterally.
Career Highlights
Zdenek Hlinak is associated with the Research Institute of Pharmacy and Biochemistry, where he continues to develop his innovative ideas. His work focuses on advancing medical treatments that address critical health issues related to the brain and nervous system.
Collaborations
Hlinak collaborates with esteemed colleagues such as Evzen Kasafirek and Ivan Krejci. Their combined expertise enhances the research and development of neuroprotective therapies.
Conclusion
Zdenek Hlinak's contributions to neuroprotection exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the field of neurology.